Skip to main navigation Skip to search Skip to main content

HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of

  • Adjuvant Trastuzumab
  • , Suthinee Ithimakin
  • , Kathleen C. Day
  • , Fayaz Malik
  • , Qin Zen
  • , Scott J. Dawsey
  • , Tom F. Bersano-Begey
  • , Ahmed A. Quraishi
  • , Kathleen Woods Ignatoski
  • , Stephanie Daignault
  • , April Davis
  • , Christopher L. Hall
  • , Nallasivam Palanisamy
  • , Amber N. Heath
  • , Nader Tawakkol
  • , Tahra K. Luther
  • , Shawn G. Clouthier
  • , Whitney A. Chadwick
  • , Mark L. Day
  • , Celina G. Kleer
    • Dafydd G. Thomas, Daniel F. Hayes, Hasan Korkaya, Max S. Wicha

Research output: Contribution to journal › Article › peer-review

215   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry